Market revenue in 2023 | USD 1,690.4 million |
Market revenue in 2030 | USD 2,403.3 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Corticosteroids |
Fastest growing segment | Corticosteroids |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Corticosteroids |
Key market players worldwide | AbbVie Inc, Teva Pharmaceutical Industries Ltd, Amgen Inc, Astellas Pharma Inc, Bristol-Myers Squibb Co, Cara Therapeutics Inc, GlaxoSmithKline, Viatris Inc, Novartis AG ADR, Pfizer Inc, Sanofi SA |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pruritus therapeutics market will help companies and investors design strategic landscapes.
Corticosteroids was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Asia Pacific pruritus therapeutics market based on corticosteroids covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific pruritus therapeutics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific pruritus therapeutics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account